Gland Pharma IPO Subscribed 22% On Second Day Of Subscription
Gland Pharma's public offer will be the largest pharma IPO in the country, as per estimates. It will also be the Indian company, with Chinese parentage, to tap the primary marker for funding.
No comments:
Post a Comment